The Role of Intravenous Fosfomycin: Finding Our Way Out of Dante's Forest Dark

Pranita D Tamma¹, Robert A Bonomo^{2

3

4}, Usha Stiefel^{2

3}

Affiliations

¹ Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Medical Service, Veterans Affairs Northeast Ohio Healthcare System and Case Western Reserve University-Cleveland VA Medical Center Center for Antimicrobial Resistance and Epidemiology, Cleveland, Ohio.
³ Department of Medicine, Case Western Reserve University School of Medicine, Case Western Reserve University, Cleveland, Ohio.
⁴ Geriatric Research, Education, and Clinical Center and Case Western Reserve University-Cleveland VA Medical Center Center for Antimicrobial Resistance and Epidemiology, Louis Stokes Cleveland Department of Veterans Affairs Medical Center.

Free article

Comment

Pranita D Tamma et al. JAMA Netw Open. 2022.

Free article

. 2022 Jan 4;5(1):e2138691.

doi: 10.1001/jamanetworkopen.2021.38691.

Pranita D Tamma¹, Robert A Bonomo^{2

3

4}, Usha Stiefel^{2

3}

¹ Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Medical Service, Veterans Affairs Northeast Ohio Healthcare System and Case Western Reserve University-Cleveland VA Medical Center Center for Antimicrobial Resistance and Epidemiology, Cleveland, Ohio.
³ Department of Medicine, Case Western Reserve University School of Medicine, Case Western Reserve University, Cleveland, Ohio.
⁴ Geriatric Research, Education, and Clinical Center and Case Western Reserve University-Cleveland VA Medical Center Center for Antimicrobial Resistance and Epidemiology, Louis Stokes Cleveland Department of Veterans Affairs Medical Center.

No abstract available

Comment on

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.
Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J; REIPI-GEIRAS-FOREST group. Sojo-Dorado J, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277. JAMA Netw Open. 2022. PMID: 35024838 Free PMC article. Clinical Trial.